Skip to content
10-Q/A

Quarterly Report

Tengjun Biotechnology Corp.

0001213900-22-056649

← back to feed
Filed
Sep 16, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 9, 2022 90.31M sh
Shares Diluted Q2 2022 · Jun 30, 2022 65.31M sh
Shares Diluted Q2 2022 · Jun 30, 2022 65.31M sh
Shares Diluted Q2 2022 · Jun 30, 2021 19.29M sh
Shares Diluted Q2 2022 · Jun 30, 2021 19.29M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 $7.69M
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$141.97K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $6.76M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $285.57K
Stockholders Equity restated Q2 2022 · Jun 30, 2022 $1.9M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$2.19M
Current Liabilities restated Q2 2022 · Jun 30, 2022 $23.35M
Current Liabilities Q2 2022 · Dec 31, 2021 $16.32M
Total Liabilities restated Q2 2022 · Jun 30, 2022 $23.35M
Total Liabilities Q2 2022 · Dec 31, 2021 $16.32M
Current Assets restated Q2 2022 · Jun 30, 2022 $16.38M
Current Assets Q2 2022 · Dec 31, 2021 $4.63M
Total Assets restated Q2 2022 · Jun 30, 2022 $25.38M
Total Assets Q2 2022 · Dec 31, 2021 $14.03M
Eps Diluted restated Q2 2022 · Jun 30, 2022 $0.11
Eps Diluted restated Q2 2022 · Jun 30, 2022 $0.11
Eps Basic restated Q2 2022 · Jun 30, 2022 $0.11
Eps Basic restated Q2 2022 · Jun 30, 2022 $0.11
Net Income restated Q2 2022 · Jun 30, 2022 $3.92M
Net Income restated Q2 2022 · Jun 30, 2022 $4.14M
Net Income restated Q2 2022 · Jun 30, 2021 −$222.08K
Net Income restated Q2 2022 · Jun 30, 2021 −$388.18K
Operating Income restated Q2 2022 · Jun 30, 2022 $4.63M
Operating Income restated Q2 2022 · Jun 30, 2022 $4.96M
Operating Income restated Q2 2022 · Jun 30, 2021 −$219.42K
Operating Income restated Q2 2022 · Jun 30, 2021 −$380.55K
Gross Profit Q2 2022 · Jun 30, 2022 $47.85M
Gross Profit Q2 2022 · Jun 30, 2022 $51.77M
Revenue Q2 2022 · Jun 30, 2022 $51.29M
Revenue Q2 2022 · Jun 30, 2022 $55.57M